RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Taylor to Spironolactone

Back to Details
This is a "connection" page, showing publications Andrew Taylor has written about Spironolactone.
Andrew Taylor
Connection Strength
0.894
Spironolactone
  1. Papapostolou S, Iles L, O'Brien J, Gutman SJ, Ellims A, Hare J, Stub D, Moir S, Taylor AJ. The Antifibrotic Effects of Eplerenone in Hypertrophic Cardiomyopathy: A Randomized Clinical Trial. JACC Heart Fail. 2025 Jul; 13(7):102415.
    View in: PubMed
    Score: 0.894
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support